A detailed history of Silvant Capital Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Silvant Capital Management LLC holds 1,245 shares of AMGN stock, worth $340,395. This represents 0.02% of its overall portfolio holdings.

Number of Shares
1,245
Previous 1,245 -0.0%
Holding current value
$340,395
Previous $389,000 3.08%
% of portfolio
0.02%
Previous 0.02%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Nov 12, 2019

SELL
$174.11 - $208.62 $47,706 - $57,161
-274 Reduced 18.04%
1,245 $241,000
Q1 2018

May 09, 2018

BUY
$169.43 - $198.0 $257,364 - $300,762
1,519 New
1,519 $259,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $146B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Silvant Capital Management LLC Portfolio

Follow Silvant Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Silvant Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Silvant Capital Management LLC with notifications on news.